Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co Inventory

The Inventory of Shanghai ZJ Bio-Tech Co (688317.SS) as of Oct 22, 2026 is 45.57 M CNY. In the previous year, Inventory was 57.37 M CNY — a change of -20.56% (lower).

Inventory

45.57 MCNY

YoY

-20.56%

Last updated:

Inventory of Shanghai ZJ Bio-Tech Co is 2025 45.57 M CNY. Inventory of Shanghai ZJ Bio-Tech Co was 2024 57.37 M CNY. It decreases by -20.56% lower compared to the previous year.

The Shanghai ZJ Bio-Tech Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
32.91 M CNY
Jan 1, 2019
41.30 M CNY
Jan 1, 2020
131.73 M CNY
Jan 1, 2021
299.47 M CNY
Jan 1, 2022
504.03 M CNY
Jan 1, 2023
253.60 M CNY
Jan 1, 2024
57.37 M CNY
Jan 1, 2025
45.57 M CNY
The Shanghai ZJ Bio-Tech Co Inventory history
YEARInventoryYoY
45.57 MCNY-20.56%
57.37 MCNY-77.38%
253.60 MCNY-49.69%
504.03 MCNY+68.31%
299.47 MCNY+127.34%
131.73 MCNY+218.95%
41.30 MCNY+25.51%
32.91 MCNY+1.67%
32.37 MCNY+41.45%
22.88 MCNY-48.75%
44.65 MCNY+61.86%
27.58 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Inventory of Shanghai ZJ Bio-Tech Co is 45.57 M CNY in 2025.

Inventory of Shanghai ZJ Bio-Tech Co changed from 57.37 M CNY to 45.57 M CNY, representing a -20.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Shanghai ZJ Bio-Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co